These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 6292959
1. Anorexia and hyperphagia produced by five pharmacologic classes of hallucinogens. Vaupel DB, Morton EC. Pharmacol Biochem Behav; 1982 Sep; 17(3):539-45. PubMed ID: 6292959 [Abstract] [Full Text] [Related]
2. The identification of LSD-like hallucinogens using the chronic spinal dog. Martin WR, Vaupel DB, Nozaki M, Bright LD. Drug Alcohol Depend; 1978 Mar; 3(2):113-23. PubMed ID: 272982 [Abstract] [Full Text] [Related]
3. The effects of psychotomimetics and psychomotor stimulants on two schedules promoting response switching in the rat. Evenden J. Psychopharmacology (Berl); 2002 Oct; 163(3-4):381-90. PubMed ID: 12373438 [Abstract] [Full Text] [Related]
8. Effects of various psychotomimetic agents on the EEG and acetylcholine release from the cerebral cortex of brainstem transected cats. Domino EF, Bartolini A. Neuropharmacology; 1972 Sep; 11(5):703-13. PubMed ID: 4670597 [No Abstract] [Full Text] [Related]
14. Behavioural microanalysis of the role of dopamine in amphetamine anorexia. Towell A, Muscat R, Willner P. Pharmacol Biochem Behav; 1988 Jul; 30(3):641-8. PubMed ID: 3211973 [Abstract] [Full Text] [Related]
15. EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline. Fairchild MD, Jenden DJ, Mickey MR, Yale C. Pharmacol Biochem Behav; 1980 Jan; 12(1):99-105. PubMed ID: 6102770 [Abstract] [Full Text] [Related]
16. Actions of hallucinogens on ants (Formica pratensis)--III. Social behavior under the influence of LSD and tetrahydrocannabinol. Frischknecht HR, Waser PG. Gen Pharmacol; 1980 Jan; 11(1):97-106. PubMed ID: 6245012 [No Abstract] [Full Text] [Related]
20. Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction. Lamarque S, Taghzouti K, Simon H. Neuropharmacology; 2001 Jul; 41(1):118-29. PubMed ID: 11445192 [Abstract] [Full Text] [Related] Page: [Next] [New Search]